ZGNX Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to ZGNX (ZGNX) stock?
ZGNX (ZGNX) no longer trades on public markets. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice.
ZGNX — AI-powered stock analysis.
Last analyzed: Sep 4, 2026ZGNX: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
ZGNX Company Overview
Who Are ZGNX's Competitors?
ZGNX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| NVO Novo Nordisk A/S | $44.01 | -1.23% | $195B | 925-pillar |
| VRTX Vertex Pharmaceuticals Incorporated | $519.58 | -0.29% | $132B | 965-pillar |
| REGN Regeneron Pharmaceuticals, Inc. | $793.26 | -1.78% | $81.7B | 945-pillar |
| ARGX argenx SE | $984.04 | -1.82% | $61.2B | 975-pillar |
| UCBJY UCB S.A. | $117.06 | -1.42% | $44.6B | 679-signal |
| ALNY Alnylam Pharmaceuticals, Inc. | $247.51 | -4.07% | $33.1B | 895-pillar |
| RPRX Royalty Pharma plc | $58.75 | -3.04% | $26.0B | 725-pillar |
| INCY Incyte Corporation | $123.28 | -2.17% | $25.0B | 985-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are the Key Risks for ZGNX?
Negative return on equity (-82.9%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
- Insider selling — insiders were net sellers of roughly $3.3M recently.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 71 |
| 2026-08-24 | 71 |
| 2026-08-25 | 71 |
| 2026-08-26 | 71 |
What changed?
The score has stayed at 71.
Over the same 3 days the stock moved +0.0%.
Key Financial Metrics
Return on equity for ZGNX stands at -82.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -48.5%, showing how much profit it generates from its asset base. A current ratio of 3.63 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -15.9%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
ZGNX operates in the Biotechnology industry within the Healthcare sector. It is headquartered in Emeryville, US. The company is led by CEO Stephen Farr. ZGNX has traded publicly since 2010.
Earnings Track Record
ZGNX has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 1.6% below estimates on average.
Insider Activity
The most recent 12 insider filings for ZGNX break down as 12 sales and 0 purchases. On net that is roughly 245K shares disposed (about $3.3M), a signal worth weighing alongside the fundamentals.
ZGNX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
ZGNX Latest News
-
Merger Arbitrage Mondays - Healthcare Trust Of America To Combine With Healthcare Realty Trust
benzinga · Mar 7, 2022
-
Earnings Scheduled For November 4, 2021
· Nov 4, 2021
-
Earnings Scheduled For August 5, 2021
· Aug 5, 2021
-
Stocks That Hit 52-Week Lows On Monday
· Jul 19, 2021
Latest News
What Investors Ask About ZGNX (ZGNX)
What happened to ZGNX (ZGNX) stock?
ZGNX (ZGNX) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy ZGNX shares?
No. ZGNX stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ZGNX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ZGNX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to ZGNX. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.